Chemical Structure (F394be03 Fefc 4679 B001 4168a204a136 01)
Atorvastatin Calcium
Product Images NDC 42254-261
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42254-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (F394be03 Fefc 4679 B001 4168a204a136 02)
The text describes a graph showing the cumulative incidence in percentage over the years. It displays two data points: Aovastatn at 15% and an unidentified variable at 40%. There is also a numeric code, HR-084 050089, and a p-value of 0.0005.*
Figure 2 (F394be03 Fefc 4679 B001 4168a204a136 03)
This document seems to be presenting the results of a study involving Atorvastatin treatment on patients. The term "Cumulative Hazard" and the percentages (15 and 10) are likely related to the probability of developing adverse effects or complications over time. The drug Atorvastatin is mentioned in the middle of the page along with some numerical values, and the letters "HR" may indicate hazard ratio, which may be further elaborated on in the document. The bottom of the page seems to be displaying a graph, possibly showing the probability of experiencing a certain primary endpoint over the course of four years.*
Figure 3 (F394be03 Fefc 4679 B001 4168a204a136 04)
This is a result from a study on the effects of two doses of a drug, sorvastatin (10mg and 80mg), compared to a placebo in a group of subjects. The text shows the percentage of subjects who experienced vertigo, and the hazard ratio (HR) and p-value for the time to first major cardiovascular endpoint. It appears that the HR for the 80mg dose group was 0.78, indicating a lower risk of experiencing the endpoint compared to the placebo, with a statistically significant p-value of 0.0002. The graph shows time (in years) to the first cardiovascular endpoint for the different treatment groups.*
Atorvastatin Calcium 20mg (F394be03 Fefc 4679 B001 4168a204a136 05)
The text provides information about a medication named Atorvastatin Calcium in the form of tablets. Each tablet contains 20mg of Atorvastatin Galcium. There are 30 tablets in each package and the package has a product ID QA026130. The tablets are white, oval shaped with "PD155" on one side and "20" on the other. The manufacturer of the tablets is Pfizer Pharmaceuticals LLC located in Puerto Rico.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
